Literature DB >> 8725146

Hepatic lipase mediates the uptake of chylomicrons and beta-VLDL into cells via the LDL receptor-related protein (LRP).

A Krapp1, S Ahle, S Kersting, Y Hua, K Kneser, M Nielsen, J Gliemann, U Beisiegel.   

Abstract

The uptake of triglyceride-rich lipoproteins has been described as being mediated by apolipoprotein E and lipoprotein lipase (LpL). Proteoglycans, the LDL-receptor, and the LDL receptor-related protein (LRP) are the cellular acceptors. In addition to LpL, hepatic lipase (HL) has been shown to bind to LRP. In this study, the role of HL in lipoprotein uptake was investigated. Human chylomicrons and rabbit beta-VLDL were used as ligands for human hepatoma cells, primary human hepalocytes, normal and proteoglycan-deficient Chinese hamster ovary (CHO) cells, and normal and LDL receptor-deficient human fibroblasts. We show that HL induces stimulation of the uptake of chylomicrons and beta-VLDL into the different cell lines. HL is known to bind to heparan sulfate, and experiments on normal and proteoglycan-deficient CHO cells showed that cell surface proteoglycans are essential for HL-mediated uptake of lipoproteins. To exclude LDL receptor-mediated uptake. we performed experiments on LDL receptor-deficient fibroblasts that demonstrated that the LDL receptor was not important for the HL-mediated uptake of lipoproteins. Crosslinking experiments confirmed the binding of HL to LRP on the cell surface. To identify the region of HL involved in the interaction with LRP, we used a C-terminal fragment of LpL, known to inhibit LpL-mediated uptake. HL-mediated lipoprotein uptake was suppressed by this fragment. Our experiments indicate that HL, like LpL, can mediate the uptake of lipoproteins into cells, most probably via a C-terminal binding site. The uptake, initiated by proteoglycan binding, is mediated by LRP.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8725146

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  11 in total

1.  Positive association of the hepatic lipase gene polymorphism c.514C > T with estrogen replacement therapy response.

Authors:  Alvaro Pulchinelli; Ana Maria Massad Costa; Cristina V de Carvalho; Naiara Correa Nogueira de Souza; Mauro A Haidar; Adagmar Andriolo; Ismael D C Guerreiro da Silva
Journal:  Lipids Health Dis       Date:  2011-11-02       Impact factor: 3.876

2.  Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism.

Authors:  J D Medh; G L Fry; S L Bowen; S Ruben; H Wong; D A Chappell
Journal:  J Lipid Res       Date:  2000-11       Impact factor: 5.922

3.  Impact of combined deficiency of hepatic lipase and endothelial lipase on the metabolism of both high-density lipoproteins and apolipoprotein B-containing lipoproteins.

Authors:  Robert J Brown; William R Lagor; Sandhya Sankaranaravanan; Tomoyuki Yasuda; Thomas Quertermous; George H Rothblat; Daniel J Rader
Journal:  Circ Res       Date:  2010-06-17       Impact factor: 17.367

Review 4.  Pharmacogenetics of Lipid-lowering Therapies.

Authors:  Jose M Ordovas; Haiqing Shen
Journal:  Curr Atheroscler Rep       Date:  2002-05       Impact factor: 5.113

5.  Endothelial cell-derived lipase mediates uptake and binding of high-density lipoprotein (HDL) particles and the selective uptake of HDL-associated cholesterol esters independent of its enzymic activity.

Authors:  Juliane G Strauss; Robert Zimmermann; Andelko Hrzenjak; Yonggang Zhou; Dagmar Kratky; Sanja Levak-Frank; Gert M Kostner; Rudolf Zechner; Sasa Frank
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

6.  Mouse hepatic lipase alleles with variable effects on lipoprotein composition and size.

Authors:  Serena M Pratt; Sally Chiu; Glenda M Espinal; Noreene M Shibata; Howard Wong; Craig H Warden
Journal:  J Lipid Res       Date:  2009-11-05       Impact factor: 5.922

7.  Secretion and apparent activation of human hepatic lipase requires proper oligosaccharide processing in the endoplasmic reticulum.

Authors:  A J Verhoeven; B P Neve; H Jansen
Journal:  Biochem J       Date:  1999-01-01       Impact factor: 3.857

8.  Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in mice.

Authors:  Kristin I Stanford; Joseph R Bishop; Erin M Foley; Jon C Gonzales; Ingrid R Niesman; Joseph L Witztum; Jeffrey D Esko
Journal:  J Clin Invest       Date:  2009-10-01       Impact factor: 14.808

Review 9.  Vitamin A metabolism: an update.

Authors:  Diana N D'Ambrosio; Robin D Clugston; William S Blaner
Journal:  Nutrients       Date:  2011-01       Impact factor: 5.717

10.  Postprandial triglyceride-rich lipoproteins induce hepatic insulin resistance in HepG2 cells independently of their receptor-mediated cellular uptake.

Authors:  Tobias Tatarczyk; Christian Ciardi; Andreas Niederwanger; Michael Kranebitter; Josef R Patsch; Michael T Pedrini
Journal:  Mol Cell Endocrinol       Date:  2011-06-15       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.